Peter Dansky - Mesa Laboratories Pres Genomics
| MLAB Stock | USD 95.42 0.16 0.17% |
Insider
Peter Dansky is Pres Genomics of Mesa Laboratories
| Age | 63 |
| Address | 12100 West Sixth Avenue, Lakewood, CO, United States, 80228 |
| Phone | 303 987 8000 |
| Web | https://www.mesalabs.com |
Mesa Laboratories Management Efficiency
The current year's Return On Tangible Assets is expected to grow to -0.54. In addition to that, Return On Capital Employed is expected to decline to 0.01. At present, Mesa Laboratories' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 352.2 M, whereas Other Assets are forecasted to decline to about 3 M. Mesa Laboratories' management efficiency ratios could be used to measure how well Mesa Laboratories manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Ian Anderson | Aclaris Therapeutics | N/A | |
| Douglas Jones | Neogen | 54 | |
| MD Frcp | Aclaris Therapeutics | 63 | |
| Rishi Kacker | Natera Inc | N/A | |
| Julie Mann | Neogen | 59 | |
| Michael Bell | Guardant Health | 55 | |
| Michael MBA | Natera Inc | 44 | |
| Eric Evans | Natera Inc | N/A | |
| LLM LLM | Natera Inc | 55 | |
| James Loerop | Aclaris Therapeutics | 59 | |
| Jonathan MEng | Natera Inc | 51 | |
| Craig MD | Guardant Health | 57 | |
| Andy Ament | Guardant Health | N/A | |
| Joseph Monahan | Aclaris Therapeutics | 67 | |
| Kumud Kalia | Guardant Health | 58 | |
| Olesya CPA | Natera Inc | N/A | |
| Darya Chudova | Guardant Health | N/A | |
| Robert Doody | Aclaris Therapeutics | N/A | |
| Paul Changelian | Aclaris Therapeutics | N/A | |
| Phil Grinnell | Natera Inc | N/A | |
Management Performance
| Return On Equity | -0.94 | ||||
| Return On Asset | 0.0042 |
Mesa Laboratories Leadership Team
Elected by the shareholders, the Mesa Laboratories' board of directors comprises two types of representatives: Mesa Laboratories inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Mesa. The board's role is to monitor Mesa Laboratories' management team and ensure that shareholders' interests are well served. Mesa Laboratories' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Mesa Laboratories' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Peter Dansky, Pres Genomics | ||
| Gary Owens, COO, Vice President | ||
| Brian Archbold, Senior Improvement | ||
| John Sakys, CFO, Chief Accounting Officer and Secretary | ||
| Bryan Leo, VP Operations | ||
| Garrett Krushefski, VP Operations |
Mesa Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Mesa Laboratories a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.94 | ||||
| Return On Asset | 0.0042 | ||||
| Profit Margin | (1.18) % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 510.92 M | ||||
| Shares Outstanding | 5.39 M | ||||
| Shares Owned By Insiders | 5.73 % | ||||
| Shares Owned By Institutions | 91.82 % | ||||
| Number Of Shares Shorted | 178.8 K | ||||
| Price To Earning | 433.94 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Mesa Stock
When determining whether Mesa Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mesa Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mesa Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mesa Laboratories Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mesa Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Mesa Stock refer to our How to Trade Mesa Stock guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mesa Laboratories. If investors know Mesa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mesa Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.875 | Dividend Share 0.64 | Earnings Share (47.20) | Revenue Per Share 40.139 | Quarterly Revenue Growth 0.06 |
The market value of Mesa Laboratories is measured differently than its book value, which is the value of Mesa that is recorded on the company's balance sheet. Investors also form their own opinion of Mesa Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Mesa Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mesa Laboratories' market value can be influenced by many factors that don't directly affect Mesa Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mesa Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Mesa Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mesa Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.